Mela
Field Notes № 09 Limits

What skincare can't change

A limits note. The line between what a cream can genuinely move and what is structurally fixed, why most of what is sold as transformation sits on the fixed side, and how to tell a product that respects the boundary from one that does not.

July 2, 2026 2,023 words 10 min read

Most people have owned a product that was going to change everything. A serum bought on a promise, applied faithfully for a month, then two, watched for the transformation the label described. Sometimes something does happen: the skin looks a little brighter, a little calmer. Often the honest verdict, said quietly to the bathroom mirror, is that it did less than it swore it would. The pores are the same size they always were. The firming cream did not lift anything. The line between the brows is exactly where it was.

The usual explanation is that the product was a dud, or that it was not used long enough, or that a better one is waiting to be found. Sometimes that is true. But underneath a great deal of skincare disappointment is a quieter possibility: that the product was promising something no cream can do. Skin can be genuinely changed in some ways and not in others, and the difference is not a matter of finding the right formula. It is a matter of which side of a fixed line the promise falls on.

That line is the useful thing to understand, because most disappointing purchases are made on the wrong side of it. Some features of skin are movable, and the right care moves them. Others are set by structure and biology, and no topical product reaches them, however luxurious or expensive or well reviewed. Knowing which is which does not make skincare pointless. It makes it legible, and it makes the overpromises easy to see.

What no cream can change

Start with the fixed side, because it is where the money tends to go.

Pore size is the clearest example. The size and number of pores are set largely by factors a cream does not touch. Roh and colleagues, measuring what tracks with pore size, found it rose with sebum output, with age, and with male sex, and that hormonal shifts across the menstrual cycle moved it in women (Roh et al., 2006). Layered beneath those is an inherited tendency: visible pores run in families, part of the fixed constitution an earlier note described as the range a person's changing skin travels within. The appearance of a pore can be improved, by keeping it clear, by reducing the oil that distends it, by building collagen in the surrounding skin. But the pore itself is not permanently shrunk, and the genetic number a person is born with is not reduced. A product that promises to shrink pores for good is promising on the fixed side of the line. What it can honestly do is make them look smaller for a while.

Then there is age. Skin aging comes in two kinds, and they behave very differently. Intrinsic aging, the chronological kind written into the body's own clock, is, in the words of one review of the field by Mukherjee and colleagues, inevitable (Mukherjee et al., 2006). Extrinsic aging, the kind driven by the sun and the environment, is not. This distinction decides what is preventable and what is not, and it turns out to run right through the face. When Flament and colleagues graded the visible signs of facial aging and sorted them by cause, the pattern was clean: pigmentation was essentially a mark of sun exposure, while sagging of the tissues was essentially a mark of chronological aging, with wrinkles and texture pulled by both (Flament et al., 2013).

Sagging is worth pausing on, because it is what the most expensive creams most often claim to correct. The downward drift of the face with age is driven by deep changes: the descent of the fat pads, the slow remodeling of the bone beneath them, the loosening of the dermal and ligamentous scaffolding that holds the face up. None of that is on the surface, and none of it is reached by something spread on the skin. A cream can sit on top of sagging tissue. It cannot lift it.

The reason is not a failure of formulation but a fact of anatomy, and it has a number attached. For a molecule to pass through the outermost layer of skin and reach the living tissue below, it generally has to be smaller than about five hundred daltons, a threshold Bos and Meinardi named the five-hundred-dalton rule after surveying which compounds can cross and which cannot (Bos & Meinardi, 2000). The stratum corneum, only a few micrometers thick, is built to keep things out, and it is very good at the job. This is the quiet reason a collagen cream cannot do what its name implies. Collagen is an enormous molecule, orders of magnitude larger than the limit; spread on the skin, it cannot penetrate to the dermis where collagen is actually lost. It rests on the surface and rinses away. The products that genuinely raise collagen do not deliver it at all. They work by prompting the skin to make its own, or by preventing its breakdown, which is a slower and less cinematic mechanism than a jar of collagen suggests.

What skincare genuinely moves

None of this is an argument that skincare does not work. It is an argument about where its power actually lies, and the power is real.

On the movable side of the line sit the things that respond. The skin's barrier and its hydration, which good formulation improves measurably. Inflammation and reactivity, which can be calmed. Surface texture. Much of pigmentation. The course of acne. These are not small gains. For a person whose barrier is compromised or whose skin is inflamed, moving them is the difference between comfort and misery. The mistake is not in valuing them. It is in expecting the product that delivers them to also do the structural things it cannot.

A concrete case makes the point. Skin that has been over-exfoliated into a stinging, flaking, reddened mess, its barrier stripped, is not a fixed condition. A pared-back routine of gentle cleansing and steady moisturization, held for a few weeks, lets the barrier rebuild and the redness settle, and the change is real and visible. That is skincare doing exactly what it is good at: restoring a function that had been disrupted. The same routine will not shrink a pore or lift a cheek, and it does not need to in order to be worth doing.

And one movable lever outweighs all the others, precisely because so much of what people call aging turns out to be preventable. If the greater part of visible facial aging is extrinsic, driven by the sun, as the grading studies indicate, then the most powerful thing a skincare routine does is not correct the past but protect against the future. Prevention is where the leverage is. It is unglamorous, it shows its value slowly and mostly in the form of damage that never arrives, and it is, by a wide margin, the most effective move available.

The two things that hold up

Two interventions carry the kind of evidence the rest of the category mostly lacks, and it is worth being precise about what they do.

The first is sunscreen, and the evidence is unusually strong. In a randomized trial in Nambour, Australia, Hughes and colleagues followed more than nine hundred adults for four and a half years, assigning some to daily broad-spectrum sunscreen and letting others use it at their discretion. The daily group showed twenty-four percent less skin aging by the end (Hughes et al., 2013). The detail that matters most, and is easy to miss, is the direction of the effect: daily sunscreen slowed the accumulation of new aging. It did not reverse the aging already present. This is prevention behaving exactly as prevention behaves, and it is the strongest single result in the field.

The second is the topical retinoids, the one well-evidenced corrective. Across many studies, gathered in the review by Mukherjee and colleagues, retinoids produce genuine improvement in the skin, visible under the microscope and in the mirror, and most of it has been demonstrated in skin already aged by the sun (Mukherjee et al., 2006). They are the exception that reveals the shape of the rule: a topical that measurably improves the extrinsic, surface layer of aging while leaving the deep structural drivers untouched. They work, within limits, and the limits are the point.

Taken together, the two things that hold up are mostly about the preventable, extrinsic layer, and one of the two is preventive rather than corrective. That is the honest shape of skincare's power. It is real, it is narrower than the shelf implies, and it is weighted heavily toward protecting skin rather than rebuilding it.

How to read a claim

This gives a simple test for a product's promise, one that needs no chemistry. Ask which side of the line the claim falls on. A promise to hydrate, to calm, to clear, to protect, to improve texture or the look of pores is a promise on the movable side, and it may well be kept. A promise to shrink pores permanently, to lift or firm sagging tissue, to rebuild deep structure, to reverse the intrinsic clock, or to drive a large molecule like collagen into the skin is a promise on the fixed side, and the confidence of the marketing does not change the anatomy.

There is a middle case worth naming, because it is where honest and dishonest claims look most alike: the language of youth. A serum that says it reduces the look of sun-related dark spots is making a movable, largely preventable claim, and a fair one, since pigmentation is the sign most clearly tied to the sun. A serum beside it promising to reverse aging is reaching across the line into the intrinsic clock, which it cannot touch. The words sit inches apart on the shelf. The claims sit on opposite sides of the line.

The tell is not the price, and it is not the ingredient list, which can be immaculate on a product that still overpromises. The tell is the verb. Protect, support, improve, calm are plausible. Restore, rebuild, lift, erase, permanently change are claims a surface product is not built to keep. The more a label leans on the second kind, the more it is selling something a cream cannot be.

What this means for reading skin

A tool that reads skin honestly has to respect the same line. Mela tracks the things that move: the barrier, the state of the skin over time, the signals that genuinely shift with care and season and routine. It is built to be candid about the difference between those and the things that do not move. It does not promise to change a person's pore count, or lift their tissue, or reverse their years, because no honest reading of skin can promise that, and a tool that did would be committing the exact overclaim the line is meant to expose. What it can do is follow the movable signals carefully, and say plainly where the fixed line falls, so that attention and effort land where they can actually do something.

There is a boundary worth stating at the edge of all this. To map what cosmetics cannot change is not to say that nothing can be done about those things. It is to say that the interventions which genuinely alter deep structure are not cosmetics, and belong to the province of medicine and a qualified clinician rather than a jar on a shelf. And anything out of the ordinary, a sudden change, a new lesion, a mole that shifts, pain that does not settle, is a matter for a doctor, not a skincare routine.

The freeing thing about the line is that it turns a frustrating category into a legible one. Most disappointment with skincare is disappointment bought on the fixed side, chasing a structural change from a surface product. The care that works, works within real limits, and leans toward protecting skin rather than remaking it. Knowing where the line falls will not make anyone's pores smaller. It will keep them from paying, over and over, for the promise that they could be.

References

  • Bos, J. D., & Meinardi, M. M. H. M. (2000). The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Experimental Dermatology, 9(3), 165–169. https://doi.org/10.1034/j.1600-0625.2000.009003165.x
  • Flament, F., Bazin, R., Laquieze, S., Rubert, V., Simonpietri, E., & Piot, B. (2013). Effect of the sun on visible clinical signs of aging in Caucasian skin. Clinical, Cosmetic and Investigational Dermatology, 6, 221–232. https://doi.org/10.2147/CCID.S44686
  • Hughes, M. C. B., Williams, G. M., Baker, P., & Green, A. C. (2013). Sunscreen and prevention of skin aging: a randomized trial. Annals of Internal Medicine, 158(11), 781–790. https://doi.org/10.7326/0003-4819-158-11-201306040-00002
  • Mukherjee, S., Date, A., Patravale, V., Korting, H. C., Roeder, A., & Weindl, G. (2006). Retinoids in the treatment of skin aging: an overview of clinical efficacy and safety. Clinical Interventions in Aging, 1(4), 327–348. https://doi.org/10.2147/ciia.2006.1.4.327
  • Roh, M., Han, M., Kim, D., & Chung, K. (2006). Sebum output as a factor contributing to the size of facial pores. British Journal of Dermatology, 155(5), 890–894. https://doi.org/10.1111/j.1365-2133.2006.07465.x